ArticlePloS one2025
The association between routine immunisation and COVID-19 vaccination in small Island developing states.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesUnderstanding the link between routine immunisation (RI) performance and vaccination during an epidemic can provide insights on health systems resilience and investments to strengthen health systems. We examined the relationship between RI performance and COVID-19 vaccination coverage in small island developing states (SIDS).
methodsWe analysed immunisation and health system performance data in 55 SIDS. Our primary outcome was COVID-19 vaccination coverage at four timepoints (June 2021, December 2021, June 2022 and December 2022). We examined associations with coverage of six childhood immunisations (5-year mean annual coverage for 2015-2019), pandemic-related disruptions to RI, new vaccine introductions, health system performance measures, and economic and demographic characteristics. We calculated Spearman correlation coefficients (r) with p-values (p < 0.05 considered significant) and 95% confidence intervals for continuous variables and mean COVID-19 vaccination coverage by categorical variables.
findingsCOVID-19 vaccination coverage was higher in countries that sustained pre-pandemic RI coverage during the pandemic, and where HPV, influenza and measles-containing (second dose) vaccines had been introduced. There were weak correlations (|r| < 0.4) between coverage of COVID-19 vaccination and RI, with a few exceptions of moderate correlations with the birth dose of hepatitis B vaccine (June 2022: r = 0.421, p = 0.007; December 2022: r = 0.438, p = 0.005) and first dose of measles vaccine (December 2021: r = 0.420, p = 0.002). COVID-19 vaccination coverage was strongly correlated with the density of physicians (June 2021: 0.897, p < 0.001; December 2021: 0.785, p < 0.001) and moderately correlated with that of nurses and midwives (June 2021: 0.630, p = 0.001; December 2021: 0.605, p = 0.002). COVID-19 vaccination coverage was lower in SIDS with lower country income and development status.
conclusionsCountries that achieved high COVID-19 vaccination coverage also sustained RI coverage during the pandemic, demonstrating health system resilience. Our findings highlight the importance of having sufficient skilled health professionals and experience in introducing new vaccines targeting different age groups into national programs, particularly in small island settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.